Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Drosophilin B
2. Octahydro-5,8-dihydroxy-4,6,9,10- Tetramethyl-6-vinyl-3a,9-propano-3ah-cyclopenta- Cycloocten-1(4h)-one 8-glycolate
3. Pleuromutilin
1. Pleuromutilin
2. Drosophilin B
3. 125-65-5
4. 3-hydroxy-2,4,7,14-tetramethyl-9-oxo-4-vinyltricyclo[5.4.3.0~1,8~]tetradec-6-yl Glycolate
5. (4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl) 2-hydroxyacetate
6. [(1s,2r,3s,4s,6r,7r,8r)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-hydroxyacetate
7. Nsc121145
8. Dsstox_cid_28646
9. Dsstox_rid_82916
10. Dsstox_gsid_48720
11. Schembl217951
12. Chembl2360152
13. Amy22294
14. Tox21_113131
15. Cas-125-65-5
16. Ft-0650914
17. Q7204785
18. [(1s,2r,3s,4s,6r,7r,14r)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-hydroxyacetate
19. Tricyclo[5.4.3.0(1,8)]tetradecan-3-ol-9-one, 4-ethenyl-6-(2-hydroxyacetoxy)-2,4,7,14-tetramethyl-
| Molecular Weight | 378.5 g/mol |
|---|---|
| Molecular Formula | C22H34O5 |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 378.24062418 g/mol |
| Monoisotopic Mass | 378.24062418 g/mol |
| Topological Polar Surface Area | 83.8 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 645 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 8 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
REF. STANDARDS & IMPURITIES
USP
ABOUT THIS PAGE
A Pleuromutilin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pleuromutilin, including repackagers and relabelers. The FDA regulates Pleuromutilin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pleuromutilin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pleuromutilin supplier is an individual or a company that provides Pleuromutilin active pharmaceutical ingredient (API) or Pleuromutilin finished formulations upon request. The Pleuromutilin suppliers may include Pleuromutilin API manufacturers, exporters, distributors and traders.
click here to find a list of Pleuromutilin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pleuromutilin DMF (Drug Master File) is a document detailing the whole manufacturing process of Pleuromutilin active pharmaceutical ingredient (API) in detail. Different forms of Pleuromutilin DMFs exist exist since differing nations have different regulations, such as Pleuromutilin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pleuromutilin DMF submitted to regulatory agencies in the US is known as a USDMF. Pleuromutilin USDMF includes data on Pleuromutilin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pleuromutilin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pleuromutilin suppliers with USDMF on PharmaCompass.
Pleuromutilin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pleuromutilin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pleuromutilin GMP manufacturer or Pleuromutilin GMP API supplier for your needs.
A Pleuromutilin CoA (Certificate of Analysis) is a formal document that attests to Pleuromutilin's compliance with Pleuromutilin specifications and serves as a tool for batch-level quality control.
Pleuromutilin CoA mostly includes findings from lab analyses of a specific batch. For each Pleuromutilin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pleuromutilin may be tested according to a variety of international standards, such as European Pharmacopoeia (Pleuromutilin EP), Pleuromutilin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pleuromutilin USP).
LOOKING FOR A SUPPLIER?
